SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-19-002244
Filing Date
2019-08-22
Accepted
2019-08-22 10:30:26
Documents
7
Period of Report
2019-08-22

Document Format Files

Seq Description Document Type Size
1 6-K zk1923432.htm 6-K 14110
2 EXHIBIT 99.1 exhibit_99-1.htm EX-99.1 20055
3 EXHIBIT 99.2 exhibit_99-2.htm EX-99.2 363318
4 EXHIBIT 99.3 exhibit_99-3.htm EX-99.3 22234
5 image0.jpg GRAPHIC 65387
6 image00001.jpg GRAPHIC 5074
7 image00002.jpg GRAPHIC 31155
  Complete submission text file 0001178913-19-002244.txt   560950
Mailing Address 13 GAD FEINSTEIN STREET PARK REHOVOT P.O.B 2100 REHOVOT L3 76121
Business Address 13 GAD FEINSTEIN STREET PARK REHOVOT P.O.B 2100 REHOVOT L3 76121 97289311900
Evogene Ltd. (Filer) CIK: 0001574565 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36187 | Film No.: 191044476
SIC: 2870 Agricultural Chemicals
Office of Life Sciences